$221.42
+
$3.91 (1.80%)
End-of-day quote: 05/06/2024
NasdaqGS:BIIB
Biogen Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $766.68 | $636.99 | 0.00% | 9 | $690.32B |
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr851.40 | kr696.07 | 0.00% | 14 | kr3.80T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $148.58 | $174.55 | 0.00% | 3 | $357.58B |
| MRK | Merck | NYSE | Outperform | $127.57 | $130.51 | 0.00% | 11 | $323.11B |
| ABBV | AbbVie | NYSE | Outperform | $162.73 | $178.42 | 0.00% | 11 | $287.36B |
| AZN | AstraZeneca PLC | LSE | Outperform | £120.50 | £165.99 | 0.00% | 16 | £186.80B |
| NOVN | Novartis | SWX | Hold | CHF88.10 | CHF105.00 | 0.00% | 9 | CHF179.76B |
| ROG | Roche Holding | SWX | Hold | CHF218.50 | CHF307.83 | 0.00% | 9 | CHF176.21B |
| DHR | Danaher | NYSE | Outperform | $247.40 | $260.33 | 0.00% | 4 | $183.25B |
| AMGN | Amgen | NasdaqGS | Outperform | $299.48 | $303.65 | 0.00% | 8 | $160.65B |
| PFE | Pfizer | NYSE | Outperform | $28.16 | $32.87 | 0.00% | 6 | $159.46B |
| SAN | Sanofi | ENXTPA | Outperform | 91.02€ | 102.80€ | 0.00% | 9 | 113.65€B |
| MDT | Medtronic | NYSE | Outperform | $81.76 | $92.47 | 0.00% | 9 | $108.56B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $958.64 | $961.26 | 0.00% | 8 | $105.63B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $402.50 | $457.59 | 0.00% | 11 | $104.03B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $43.90 | $58.15 | 0.00% | 10 | $88.99B |
| GSK | GSK | LSE | Outperform | £17.34 | £17.30 | 0.00% | 12 | £70.69B |
| CSL | CSL | ASX | Outperform | $275.50 | $205.51 | 0.00% | 5 | $133.14B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.54 | $87.82 | 0.00% | 14 | $81.73B |
| ZTS | Zoetis | NYSE | Outperform | $165.95 | $220.47 | 0.00% | 5 | $75.72B |
| MRK | Merck KGaA | XTRA | Outperform | 151.95€ | 190.06€ | 0.00% | 4 | 66.06€B |
| MRNA | Moderna | NasdaqGS | Outperform | $122.13 | $135.42 | 0.00% | 1 | $46.81B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.47T |
| DSFIR | DSM-Firmenich | ENXTAM | Outperform | 103.00€ | 114.60€ | 0.00% | 0 | 27.32€B |
| BAYN | Bayer | XTRA | Hold | 28.06€ | 45.15€ | 0.00% | 4 | 27.57€B |
| DIM | Sartorius Stedim Biotech | ENXTPA | Outperform | 206.00€ | 254.69€ | 0.00% | 3 | 20.05€B |
| GMAB | Genmab A/S | CPSE | Outperform | kr2.00k | kr2.71k | 0.00% | 14 | kr129.44B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $151.22 | $245.24 | 0.00% | 7 | $19.13B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.56k | ¥2.64k | 0.00% | 0 | ¥2.79T |
| CE | Celanese | NYSE | Hold | $159.08 | $148.23 | 0.00% | 18 | $17.75B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $14.06 | $11.59 | 0.00% | 9 | $15.92B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $82.10 | $111.56 | 0.00% | 5 | $15.59B |
| SY1 | Symrise | XTRA | Outperform | 101.15€ | 106.97€ | 0.00% | 5 | 14.08€B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $135.04 | $158.66 | 0.00% | 6 | $12.63B |
| 500124 | Dr. Reddy's Laboratories | BSE | Hold | Rp6.30k | Rp5.67k | 0.00% | 25 | Rp1.03T |
| 4523 | Eisai | TSE | Outperform | ¥6.55k | ¥9.58k | 0.00% | 0 | ¥1.86T |
| UTHR | United Therapeutics | NasdaqGS | Outperform | $260.51 | $284.08 | 0.00% | 3 | $11.64B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr282.00 | kr293.00 | 0.00% | 6 | kr97.00B |
| CRDA | Croda International Plc | LSE | Outperform | £47.46 | £65.12 | 0.00% | 6 | £6.43B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $42.28 | $55.60 | 0.00% | 3 | $6.12B |
| GRF | Grifols | BME | Outperform | 9.52€ | 18.48€ | 0.00% | 3 | 5.32€B |
| WCH | Wacker Chemie | XTRA | Outperform | 102.40€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF13.93 | CHF16.11 | 0.00% | 6 | CHF4.53B |
| PRGO | Perrigo Co PLC | NYSE | Outperform | $33.43 | $44.75 | 0.00% | 0 | $4.43B |
| BIOCON | Biocon | NSEI | Hold | Rp300.60 | Rp270.86 | 0.00% | 14 | Rp356.47B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.10 | $33.27 | 0.00% | 3 | $4.06B |
| 4403 | NOF | TSE | Buy | ¥2.12k | ¥7.63k | 0.00% | 0 | ¥507.31B |
| TGTX | TG Therapeutics | NasdaqCM | Outperform | $16.51 | $29.44 | 0.00% | 6 | $2.38B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $26.25 | $28.13 | 0.00% | 0 | $2.24B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Outperform | $25.37 | $23.40 | 0.00% | 4 | $2.09B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥4.39k | ¥8.34k | 0.00% | 0 | ¥293.93B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $5.75 | $9.21 | 0.00% | 3 | $602.86M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $11.87 | $19.33 | 0.00% | 3 | $574.86M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.80 | $6.34 | 0.00% | 0 | $511.42M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.75 | $10.21 | 0.00% | 7 | $443.16M |
| AMRN | Amarin | NasdaqGM | Underperform | $0.98 | $2.05 | 0.00% | 1 | $378.19M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $2.22 | $10.86 | 0.00% | 3 | $222.46M |
| PYC | PYC Therapeutics | ASX | Buy | $0.11 | $0.30 | 0.00% | 1 | $294.90M |
| NKTR | Nektar Therapeutics | NasdaqCM | Hold | $1.65 | $2.75 | 0.00% | 2 | $171.69M |
| MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.17 | $0.65 | 0.00% | 0 | $56.27M |
| ACST | Acasti Pharma | NasdaqCM | Buy | $2.95 | $16.34 | 0.00% | 0 | $26.98M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.43 | $200.00 | 0.00% | 1 | $15.89M |
| 542934 | Chandra Bhagat Pharma | BSE | - | Rp119.40 | Rp0.00 | 0.00% | 0 | Rp866.55M |
| ENZN | Enzon Pharmaceuticals | OTCPK | - | $0.09 | $16.00 | 0.00% | 0 | $8.48M |
| NPHC | Nutra Pharma | OTCPK | - | $0.00 | $0.53 | 0.00% | 0 | $0.01M |
| CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
